vs
Side-by-side financial comparison of Neuphoria Therapeutics Inc. (NEUP) and PCB BANCORP (PCB). Click either name above to swap in a different company.
PCB BANCORP is the larger business by last-quarter revenue ($29.2M vs $15.0M, roughly 1.9× Neuphoria Therapeutics Inc.).
Neuphoria Therapeutics Inc is a clinical-stage biopharmaceutical company focused on researching and developing innovative targeted therapies for unmet medical needs in neurological and psychiatric conditions, including anxiety, treatment-resistant depression, and other central nervous system disorders. Its core R&D efforts prioritize delivering safer, more effective treatment options for patient groups with limited existing care alternatives.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
NEUP vs PCB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.0M | $29.2M |
| Net Profit | $11.3M | — |
| Gross Margin | — | — |
| Operating Margin | 79.8% | 45.0% |
| Net Margin | 75.1% | — |
| Revenue YoY | — | 11.3% |
| Net Profit YoY | — | — |
| EPS (diluted) | $6.55 | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $29.2M | ||
| Q3 25 | — | $30.4M | ||
| Q2 25 | — | $29.3M | ||
| Q1 25 | $15.0M | $26.9M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | — | $25.3M | ||
| Q2 24 | — | $24.2M | ||
| Q1 24 | — | $23.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | $11.3M | $7.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $6.3M | ||
| Q1 24 | — | $4.7M |
| Q4 25 | — | 45.0% | ||
| Q3 25 | — | 52.3% | ||
| Q2 25 | — | 43.3% | ||
| Q1 25 | 79.8% | 40.2% | ||
| Q4 24 | — | 39.3% | ||
| Q3 24 | — | 42.2% | ||
| Q2 24 | — | 36.3% | ||
| Q1 24 | — | 27.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 37.5% | ||
| Q2 25 | — | 31.0% | ||
| Q1 25 | 75.1% | 28.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 30.8% | ||
| Q2 24 | — | 25.9% | ||
| Q1 24 | — | 19.6% |
| Q4 25 | — | $0.65 | ||
| Q3 25 | — | $0.78 | ||
| Q2 25 | — | $0.62 | ||
| Q1 25 | $6.55 | $0.53 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $0.52 | ||
| Q2 24 | — | $0.43 | ||
| Q1 24 | — | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $17.0M | $207.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $26.0M | $390.0M |
| Total Assets | $30.7M | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $207.1M | ||
| Q3 25 | — | $369.5M | ||
| Q2 25 | — | $263.6M | ||
| Q1 25 | $17.0M | $214.3M | ||
| Q4 24 | — | $198.8M | ||
| Q3 24 | — | $193.1M | ||
| Q2 24 | — | $177.6M | ||
| Q1 24 | — | $239.8M |
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $384.5M | ||
| Q2 25 | — | $376.5M | ||
| Q1 25 | $26.0M | $370.9M | ||
| Q4 24 | — | $363.8M | ||
| Q3 24 | — | $362.3M | ||
| Q2 24 | — | $353.5M | ||
| Q1 24 | — | $350.0M |
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.3B | ||
| Q1 25 | $30.7M | $3.2B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.5M | $26.6M |
| Free Cash FlowOCF − Capex | — | $24.4M |
| FCF MarginFCF / Revenue | — | 83.6% |
| Capex IntensityCapex / Revenue | — | 7.5% |
| Cash ConversionOCF / Net Profit | 1.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $26.6M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | $11.5M | $2.3M | ||
| Q4 24 | — | $39.0M | ||
| Q3 24 | — | $11.9M | ||
| Q2 24 | — | $14.6M | ||
| Q1 24 | — | $8.2M |
| Q4 25 | — | $24.4M | ||
| Q3 25 | — | $16.2M | ||
| Q2 25 | — | $3.8M | ||
| Q1 25 | — | $1.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | — | $11.9M | ||
| Q2 24 | — | $12.8M | ||
| Q1 24 | — | $6.0M |
| Q4 25 | — | 83.6% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 133.2% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 53.1% | ||
| Q1 24 | — | 25.2% |
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | — | 9.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | 1.02× | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 2.33× | ||
| Q1 24 | — | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
